Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial.

Nianhua DingJian PangXuan LiuXiongbin HeWei ZhouHaiqing XieJianqi FengGuo WangJie TangJing CaoLiying HeYingjian HeShouman WangZhi Xiao

Published in: Breast cancer research : BCR (2024)

A low baseline NLR is associated with better survival outcomes among HER2-positive MBC patients receiving docetaxel plus trastuzumab/pertuzumab as first-line therapy.

Keyphrases

metastatic breast cancer
study protocol
electronic health record
phase iii
big data
phase ii
peripheral blood
squamous cell carcinoma
free survival
radiation therapy
mesenchymal stem cells
bone marrow
artificial intelligence
tyrosine kinase